IN2013MU03491A - - Google Patents

Download PDF

Info

Publication number
IN2013MU03491A
IN2013MU03491A IN3491MU2013A IN2013MU03491A IN 2013MU03491 A IN2013MU03491 A IN 2013MU03491A IN 3491MU2013 A IN3491MU2013 A IN 3491MU2013A IN 2013MU03491 A IN2013MU03491 A IN 2013MU03491A
Authority
IN
India
Prior art keywords
treosulfan
relates
present
improved
methylsulfonyloxybutyl
Prior art date
Application number
Other languages
English (en)
Inventor
Sougata Pramanick
Vikram Shamrao Gharge
Krishna Barsu Kinage
Rushil Vidhyutbhai Shah
Mukund Keshav Gurjar
Samit Satish Mehta
Original Assignee
Emcure Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emcure Pharmaceuticals Ltd filed Critical Emcure Pharmaceuticals Ltd
Priority to IN3491MU2013 priority Critical patent/IN2013MU03491A/en
Priority to PCT/IN2014/000692 priority patent/WO2015107534A1/en
Publication of IN2013MU03491A publication Critical patent/IN2013MU03491A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IN3491MU2013 2013-11-04 2014-10-31 IN2013MU03491A (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN3491MU2013 IN2013MU03491A (pl) 2013-11-04 2014-10-31
PCT/IN2014/000692 WO2015107534A1 (en) 2013-11-04 2014-10-31 Lyophilized formulation of treosulfan

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3491MU2013 IN2013MU03491A (pl) 2013-11-04 2014-10-31

Publications (1)

Publication Number Publication Date
IN2013MU03491A true IN2013MU03491A (pl) 2015-07-31

Family

ID=53039936

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3491MU2013 IN2013MU03491A (pl) 2013-11-04 2014-10-31

Country Status (2)

Country Link
IN (1) IN2013MU03491A (pl)
WO (1) WO2015107534A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7431815B2 (ja) * 2018-09-26 2024-02-15 メダック ゲゼルシャフト フィア クリニッシェ スペツィアルプレパラーテ ミット ベシュレンクタ ハフトゥンク トレオスルファンの結晶形
PT4257122T (pt) * 2018-09-26 2026-06-08 Medac Ges Fr Klinische Spezialprparate Mbh Liofilizado de treossulfano
EP3856252A1 (en) 2018-09-26 2021-08-04 medac Gesellschaft für klinische Spezialpräparate mbH Solution comprising treosulfan

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155702A (en) 1960-02-22 1964-11-03 Lphivens Kemiske Fabrik Ved A Stereoisomers and the racemate of butane-1, 2, 3, 4-tetrol-1, 4-di
AU2003218110A1 (en) * 2002-03-12 2003-09-29 Bristol-Myers Squibb Company C3-cyano epothilone derivatives
WO2008135232A1 (en) * 2007-05-02 2008-11-13 Riccardo Cortese Use and compositions of purine derivatives for the treatment of proliferative disorders
DE102009022046A1 (de) * 2009-05-16 2010-11-18 Evoria Gmbh Entfärbte Extrakte der Pflanze Pandanus conoideus

Also Published As

Publication number Publication date
WO2015107534A1 (en) 2015-07-23

Similar Documents

Publication Publication Date Title
PH12020550552A1 (en) Inhibitors of hepatitis c virus
EA201591748A1 (ru) Модуляторы p2x7
NZ729443A (en) Heterocyclic modulators of lipid synthesis
PH12015501996B1 (en) Heterocyclic compounds and uses thereof
NZ711982A (en) Cytotoxic and anti-mitotic compounds, and methods of using the same
EA201400833A1 (ru) Новые индолизиновые соединения, способ их получения и фармацевтические композиции, содержащие их
EA201591728A1 (ru) Гетероциклические соединения и способы их применения
MY186547A (en) 4?-fluoro-2?-methyl substituted nucleoside derivatives
PH12017501539A1 (en) Disacetoxytubulysin h and analogs thereof
EA201600124A1 (ru) Новые индолизиновые соединения, способ их получения и фармацевтические композиции, содержащие их
ZA201600415B (en) Novel derivatives of indole and pyrrole, method for the production thereof and pharmaceutical compositions containing same
MY168212A (en) A new therapeutical composition containing apomorphine as active ingredient
EA201600122A1 (ru) Новые изоиндолиновые или изохинолиновые соединения, способ их получения и фармацевтические композиции, содержащие их
GEP201706760B (en) Novel abexinostate salt, associated crystalline form, preparation method thereof and the pharmaceutical compositions containing same
EA201500821A1 (ru) Производные 2-замещенных-6-биарилметиламино-9-циклопентил-9н-пуринов, их использование в качестве лекарственных средств и фармацевтических составов
EP3003360A4 (en) High potency pancreatin pharmaceutical compositions
EA201600394A1 (ru) Трициклические соединения пиперидина
WO2012061012A3 (en) 4-amino-2h-pyran-2-one analogs as anticancer agents
PL3004058T3 (pl) Związki-inhibitory acetylcholinesterazy i agoniści receptorów serotoninergicznych 5ht4, o działaniu propamięciowym, ich sposoby wytwarzania i zawierające je kompozycje farmaceutyczne
MX367773B (es) Forma salina sólida de la alfa-6-mpeg6-o-hidroxicodona como agonistas opioides y sus usos.
IN2013CH04314A (pl)
ME01524B (me) Derivati dihidrobenzoksatiazepina, postupak njihove pripreme i farmaceutska jedinjenja koja ih sadrže te njihova upotreba kao modulatora ampa receptora
EA201590886A1 (ru) Замещенные производные индола
UA114396C2 (uk) Фармацевтична композиція з антиішемічною та антигіпертензивною дією
IN2013MU03656A (pl)